Tech Company Financing Transactions
Rennovia Funding Round
Private investors participated in a $23.3 million Series B funding round for Rennovia. The round was announced by the company on 2/17/2014.
Transaction Overview
Company Name
Announced On
2/17/2014
Transaction Type
Venture Equity
Amount
$23,320,658
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Advanced Materials
Mailing Address
3040 Oakmead Village Dr.
Santa Clara, CA 95051
USA
Santa Clara, CA 95051
USA
Phone
Website
Email Address
Overview
Rennovia is developing advanced chemo-catalytic processes for the conversion of bio-derived, renewable feedstocks to major-market chemical products. These processes are designed to be readily scalable and to employ standard chemical production and purification equipment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Wedinger
Chief Financial Officer
Michelle Cheung
VP - Bus. Development
Thomas Boussie
VP - General Counsel
John Borkholder
VP - Manufacturing
Kenneth Keckler
VP - Product Management
Gary Diamond
VP - R & D
Vincent Murphy
Browse more venture capital transactions:
Prev: 2/17/2014: PandoDaily venture capital transaction
Next: 2/17/2014: RoomHunt venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC transactions on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs